Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed‐ratio combination: a post hoc analysis of the LixiLan‐O and LixiLan‐L trials-Reference-Cited by-同舟云学术

Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed‐ratio combination: a post hoc analysis of the LixiLan‐O and LixiLan‐L trials

Published:2019-11-26 Issue:2 Volume:37 Page:256-266
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Davidson J. A.¹^ORCID,Desouza C.²,Fonseca V.³,Frias J. P.⁴,Van Gaal L.⁵,Giorgino F.⁶,Chao J.⁷,Dex T. A.⁸,Roberts M.⁸,Saremi A.⁸,Leiter L. A.⁹^ORCID

Affiliation:

1. Touchstone Diabetes Center, Department of Internal Medicine The University of Texas Southwestern Medical Center Dallas TXUSA

2. University of Nebraska Medical Center Omaha NEUSA

3. Tulane University Health Sciences Center New Orleans LAUSA

4. National Research Institute Los Angeles CA USA

5. Antwerp University Hospital Edegem‐Antwerp Belgium

6. University of Bari Aldo Moro Bari Italy

7. Xinyi, Inc. BridgewaterNJUSA

8. Sanofi US, Inc. Bridgewater NJ USA

9. Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto Toronto ON Canada

Funder

Sanofi

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14094

Reference24 articles.

1. Control of Postprandial Glucose Levels with Insulin in Type 2 Diabetes

2. 6. Glycemic Targets: Standards of Medical Care in Diabetes—2018

3. Postprandial hyperglycaemia and vascular damage - the benefits of acarbose

4. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

5. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. iGlarLixi effectively reduces residual hyperglycaemia in patients with type 2 diabetes on basal insulin: A post hoc analysis from the LixiLan‐L study;Diabetes, Obesity and Metabolism;2020-05-28

2. Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes;Journal of Clinical Medicine;2020-03-26